Animal Health Products Antibacterials Markets
| Publication Date | May 2008 |
|---|---|
| Publisher | TriMark Publications |
| Product Type | Report |
| Pages | 70 |
| ISBN Number | not applicable |
| Product Code | TRI00071 |
Summary
Veterinary antibacterials-antiseptics that only act against bacteria-comprise some of the most important pharmaceutical products on the animal health market. Yet despite a difficult regulatory environment-driven by concerns over the development of antibacterial resistance in consumers of livestock products-new products are still being launched. This has resulted in significant changes in the animal health products market. This study offers a detailed examination of the shape of the animal health products market globally over the next several years specific to antibacterials, analyzing both the livestock and companion animal markets.
Content
- 1 Report Overview
- 1.1 Objectives of Report
- 1.2 Scope of Report
- 1.3 Methodology
- 1.4 Executive Summary
- 2 Animal Health Products Markets
- 2.1 Overview
- 2.2 Overview of Health Products Market
- 2.2.1 World Products Markets
- 2.2.2 U.S. Animal Health Products Market
- 2.2.3 European Animal Health Markets
- 2.2.4 Asian Animal Health Products Markets
- 2.3 Key Sector Highlights
- 2.4 Biologicals Products Category
- 2.5 Companion Animal Health Products
- 2.6 Commercially Significant Bacterial Infections in Farm Animals
- 2.7 Common Animal Diseases
- 3 Antibacterals Markets
- 3.1 Overview
- 3.2 Antibiotics Market Size
- 3.3 Global Sales of Animal Health Antibiotics by Region
- 3.3.1 U.S. Sales of Animal Health Antibiotics
- 3.3.2 European Sales of Animal Health Antibiotics
- 3.3.3 Japanese Sales of Animal Health Products
- 3.4 Key Findings
- 3.5 Animal Health Antibiotics Market Drivers
- 3.6 Sector Comments
- 3.7 Growth Promotion in Livestock
- 4 Regulatory Overview of The Veterinary Health Market
- 4.1 Regulatory Environment
- 4.2 General Overview
- 4.3 Product Marketing Authority
- 4.4 Regulation of Animal Health Products in The European Union
- 4.5 Regulation of Animal Health Products in The U.S
- 4.5.1 Usda
- 4.5.2 Fda
- 4.5.3 Epa
- 4.6 Regulation of Animal Health Products in Japan
- 4.6.1 Japanese Regulatory Environment
- 4.6.2 Withdrawal Periods
- 4.6.3 Japanese Filing Procedures for New Animal Drug Applications
- 4.6.4 Use of Outdated Animal Studies
- 4.7 Brand-Specific Listing for Antimicrobial Antibiotic and Other Feed Additives
- 4.8 Proposed Regulation of Animal Antibiotics
- 4.9 Antibiotic Acquired Resistance and Animal Usage
- 5 Business Trends in The Industry
- 5.1 The European Animal Health Industry
- 5.2 Trends Driving Demand
- 5.3 Antibiotic Usage
- 5.4 Mergers and Acquisitions
- 5.5 New Product Launches
- 5.6 Bioterrorism and Food Borne Pathogens?Who Guidelines
- 5.7 Animal Health Additive Growth Trends
- 6 Company Profiles
- 6.1 Abbott Laboratories
- 6.2 Agricultural Research Service
- 6.3 Alpharma Inc
- 6.4 Basf Agricultural Products and Nutrition
- 6.5 Bayer Animal Health
- 6.6 Boehringer Ingelheim Corp
- 6.7 Elanco Animal Health
- 6.8 Fort Dodge Animal Health (Wyeth)
- 6.9 Heska Animal Health
- 6.10 Intervet International
- 6.11 Ivax Corporation
- 6.12 Merial Animal Health
- 6.13 Novartis Animal Health
- 6.14 Pfizer Animal Health
- 6.15 Roche Animal Nutrition and Health
- 6.16 Sanofi-Aventis
- 6.17 Schering-Plough Animal Health
- 6.18 Virbac S.A
- 6.19 Wyeth (Fort Dodge Animal Health)
- Index of Figures
- Figure 2.1: Worldwide Sales of Animal Health Products Market by Product Class, 2006
- Figure 2.2: Worldwide Animal Health Products Market by Region, 2006
- Figure 2.3: U.S. Companion Animal Healthcare Products Share of Overall Animal Health Product Sales, 2006
- Figure 2.4: Worldwide Animal Health Products Market by Species, 2006
- Ndex of Tables
- Table 2.1: World Market for Animal Health Products, 2004-2012
- Table 2.2: Global Sales of Animal Health and Nutrition Products, 2004-2012
- Table 2.3: Worldwide Animal Health Products Market by Region, 2006
- Table 2.4: U.S. Animal Health Product Sales, 2004-2012
- Table 2.5: Japanese Animal Health Market, 2000-2012
- Table 2.6: Worldwide Animal Health Product Sales for Leading Producers, 2006
- Table 2.7: Dog and Cat Food Manufacturers
- Table 2.8: Commercially Significant Bacterial Infections in Pigs
- Table 2.9: Commercially Significant Bacterial Infections in Poultry
- Table 2.10: Commercially Significant Bacterial Infections in Cattle
- Table 2.11: List A Diseases
- Table 2.12: List B Diseases
- Table 2.13: Cattle Diseases
- Table 2.14: Sheep and Goat Diseases
- Table 2.15: Equine Diseases
- Table 2.16: Swine Diseases
- Table 2.17: Avian Diseases
- Table 2.18: Fish Diseases
- Table 2.19: Other Veterinary Diseases
- Table 3.1: Antimicrobials
- Table 3.2: Worldwide Sales of Animal Health Antibiotics, 2004-2012
- Table 3.3: U.S. Sales of Animal Health Antibiotics, 2004-2012
- Table 3.4: U.S. Volume of Animal Health Antibiotics Used, 1999-2006
- Table 3.5: Sales of Bayer's Baytril, 2003-2009
- Table 3.6: Enrofloxacin (Quinolones)
- Table 3.7: U.S. Volume of Animal Health Antibiotics Used by Class Category, 2000-2005
- Table 3.8: European Sales of Animal Health Antibiotics, 2004-2012
- Table 3.9: European Veterinary Consumption of Therapeutic Antibiotics
- Table 3.10: Japanese Sales of Animal Health Antibiotics, 2004-2012
- Table 3.11: Animal Health Antibiotics Market Drivers
- Table 3.12: Commercial Animal Health Antibacterials by Class Type
- Table 3.13: Bacterial and Protozoal Threats to Poultry
- Table 3.14: Bacterial and Protozoal Threats to Pigs
- Table 6.2: Alpharma Loss and Discontinued Operations by Business Segment, 2004-2006
- Table 6.3: Pfizer Animal Health Products
- Table 6.4: Pfizer Product Patents, 2006-2012
- Table 6.5: Key Pfizer Animal Health Products
- Table 6.6: Pfizer Livestock Products
- Table 6.7: Pfizer Equine Products
- Table 6.8: Pfizer Companion Animal Products
About this Product
Delivery Details
Related Products
Recently Viewed Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















